Overview

Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker

Status:
Recruiting

Trial end date:
2022-08-01

Target enrollment:

Participant gender:

Summary

Researchers are assessing the effects of weight loss medication vs a placebo among participants provided with a wearable activity tracker, digital wellness devices and lifestyle recommendations.

Phase:

Phase 4

Details

Lead Sponsor:

Mayo Clinic

Treatments:

Phentermine
Topiramate